These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 15177946

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Presentation, treatment, and outcome of type 1 gastric carcinoid tumors.
    Dakin GF, Warner RR, Pomp A, Salky B, Inabnet WB.
    J Surg Oncol; 2006 Apr 01; 93(5):368-72. PubMed ID: 16550587
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficient symptomatic control of carcinoid tumors with somatostatin in patients with disease progression under alpha-interferon therapy.
    Boehme MW, Schmidt-Gayk H, Bihl H, Eisenhut M, Herfarth CH, Kommere B, Raeth U.
    Hepatogastroenterology; 1995 Apr 01; 42(6):1053-61. PubMed ID: 8847018
    [Abstract] [Full Text] [Related]

  • 9. Immunostaining for vasostatin I distinguishes between ileal and lung carcinoids.
    Cunningham RT, Pogue KM, Curry WJ, Johnston CF, Sloan JM, Buchanan KD.
    J Pathol; 1999 Feb 01; 187(3):321-5. PubMed ID: 10398086
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours.
    Bernini GP, Moretti A, Ferdeghini M, Ricci S, Letizia C, D'Erasmo E, Argenio GF, Salvetti A.
    Br J Cancer; 2001 Mar 02; 84(5):636-42. PubMed ID: 11237384
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prospective study of the ability of serial measurements of serum chromogranin A and gastrin to detect changes in tumor burden in patients with gastrinomas.
    Abou-Saif A, Gibril F, Ojeaburu JV, Bashir S, Entsuah LK, Asgharian B, Jensen RT.
    Cancer; 2003 Jul 15; 98(2):249-61. PubMed ID: 12872342
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Plasma chromogranin-A (CgA)--a potential marker for diagnosis, monitoring and management of prostate cancer patients].
    Leibovitch I, Pinthus Y, Sella BA, Ramon J.
    Harefuah; 2006 Jan 15; 145(1):25-9, 78. PubMed ID: 16450720
    [Abstract] [Full Text] [Related]

  • 18. The role of serum chromogranin A in diarrhoea predominant irritable bowel syndrome.
    Sidhu R, McAlindon ME, Leeds JS, Skilling J, Sanders DS.
    J Gastrointestin Liver Dis; 2009 Mar 15; 18(1):23-6. PubMed ID: 19337629
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Biochemical diagnosis of neuroendocrine GEP tumor.
    Oberg K.
    Yale J Biol Med; 1997 Mar 15; 70(5-6):501-8. PubMed ID: 9825477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.